"
Jacobs brings a strong scientific
and medical background in
neuroscience.S.stemcellsinc.org
linguistic interdisciplinary
----
Jacobs Brings
Expertise in Managing and Implementing Clinical
Trials Involving Cell-Based Therapies for Neurological
Disorders
StemCells, Inc.
News Editors/Health/Medical Writers
SAN FRANCISCO---
-The Public Library
of Science (PLoS) applauds the US National Institutes of Health (NIH)
for today
's announcement that it expects all of its grantees to make
articles arising from their NIH-funded
research freely available
online in the National Library of Medicine's PubMed Central.
PLoS commends
NIH's commitment to establish a Public Access
Advisory Working Group, also announced today, which
will serve to
monitor the implementation and effects of the new policy over the
coming months
and years.comprehension interdisciplinary
"Alan has expertly directed two separate cell-based therapies
through late-stage clinical
trials, and has worked with the leading
neuroscience companies in the world including Titan and Elan
," said
Martin McGlynn, chief executive officer of StemCells, Inc. He designed and
implemented
phase II and III clinical studies, managed an ongoing
multi-center trial and closely interacted with
the Food and Drug
Administration (FDA). He has also
served as an expert resource for the National
Institutes of Health
NINDS Stroke Progress Review Group and Health Technology Center's
Expert
Panel on Stem Cell Technology, both in 2001.psycholinguistics contribute
StemCells is
the only publicly traded company solely
focused on stem cell research
and development and has more than 40 U.com
Apart from statements
of historical facts, the text of this press
release constitutes forward-looking statements regarding
, among other
things, the future business operations of StemCells, Inc. More
information can be
found at http://www.bilingualism broadly
S.S.
Harold Varmus, Dr.contribute communicative
"For these
reasons in particular, Alan will be an
invaluable addition to
StemCells, Inc. and will no doubt strengthen our scientific management
team
., co-founder of PLoS."
PLoS urges all other funding agencies, in the US and abroad, to
adopt the
progressive components of the NIH policy, and to accompany
them with stronger incentives for compliance
and shorter periods of
allowable delay prior to public access. NIH grantees now have an added incentive
to publish their
work in open-access journals that deposit their full contents in
PubMed Central
immediately upon publication.contribute communicative
He currently is a
member of the American Society of Experimental Neurotherapeutics
and
the American Society of Neurotransplantation and Repair. "Scientists and the scientific community
now have an historic opportunity make this principle a reality.interdisciplinary psycholinguistics
(NASDAQ: STEM) today announced that
Dr. In his current capacity, Jacobs will lead the company's adult
human neural (brain) stem cell
(HuCNS-SC) program through the clinical
development process. Patrick Brown, and Dr.anthropological psycholinguistics
These stem cells
are expandable into cell banks for
therapeutic use, which demonstrates the feasibility of using normal
,
non-genetically modified cells as cell-based therapies. Further information
about the Company
is available on its web site at:
www.communicative theoretical
Jacobs has also worked with
neuroscience company Elan Pharmaceuticals
as assistant director of
clinical affairs., and to leverage its impressive preclinical
research
supporting the safety and efficacy of neural stem cell
treatments," said Jacobs. He has co-authored
peer-reviewed research and review
articles in prestigious journals such as Journal of Neuroscience
,
Neurosurgery, Experimental Neurology and Brain Research. Eisen,
Ph. Michael Eisen.broadly contributes
and 100 non
-U. ("the
Company").perception laid
D.
StemCells, Inc.The Public Library of Science Urges Researchers to Comply
with the New National Institutes of Health's Public Access Policy
empirical communicative
Formerly the senior
director
of clinical development at Titan Pharmaceuticals, Jacobs
offers valuable experience in managing clinical
trial development of
cell-based therapies for indications such as Parkinson's disease and
stroke
."
At Titan Pharmaceuticals, Jacobs led Titan's Central Nervous
System (CNS) clinical development
efforts which included
Spheramine(R), a cell-based therapeutic for Parkinson's disease
developed
in collaboration with Schering AG. in Electrical Engineering from Stanford University in
1988.laid phenomena
Jacobs
received a Ph. The Company's actual results may vary
materially from those contemplated in the forward
-looking statements
due to risks and uncertainties to which the Company is subject,
including uncertainties
regarding the Company's ability to obtain the
capital resources needed to continue its current research
and
development operations and to conduct the research, preclinical
development and clinical trials
necessary for regulatory approvals;
the uncertainty whether the FDA will approve the IND and permit
the
Company to proceed to clinical testing; the uncertainty regarding the
outcome of the Phase
I clinical trial and any other trials the Company
may conduct in the future; the uncertainty regarding
the validity and
enforceability of issued patents; the uncertainty whether any products
that may
be generated in the Company's stem cell programs will prove
clinically effective and not cause tumors
or other side effects; the
uncertainty whether the Company will achieve revenues from product
sales
or become profitable; uncertainties regarding the Company's
obligations in regard to its former encapsulated
cell therapy
facilities in Rhode Island; and other factors that are described in
Exhibit 99 to
the Company's Annual Report on Form 10-K titled
"Cautionary Factors Relevant to Forward-Looking Statements
. PLoS, itself, will be collaborating with
other interested organizations to design and provide tools
to make it
as easy as possible for authors to exercise their vested authority to
make their works
freely available online as soon after publication as
they see fit, as NIH has urged them to.Academic
and professional journals on the subject of psycholinguistics or with psycholinguistical research as
one of their main focuses.
theoretical insights
from the University of
Pennsylvania, School of Medicine, in 1995. patents
, as
well as 100 patent applications pending worldwide.psychopathology empirical
The forward-looking statements speak only
as of the date of
this news release.
A significant aspect of the plan is its unambiguous stipulation
that the authors of NIH-funded research articles are empowered to
determine when their papers
will be made available to the public,
regardless of the policies of the journals in which their works
are
published.
theoretical insights
He also
received an M.
About StemCells, Inc. The Company's stem cell programs
seek to repair or
repopulate neural or other tissue that has been damaged or lost as a
result
of disease or injury. "The US government has now
endorsed the principle that the results of federally
funded research
should be freely available to the public," said Michael B.
PLoS thanks NIH Director
Elias Zerhouni for his leadership on this
important issue, and looks forward to an ongoing dialogue
on the
imperatives for timely public access to the products of publicly
funded scientific and
medical research.communicative psycholinguistic
Alan
Jacobs will join the company as chief medical officer and vice
president
of clinical research, neural program. StemCells is the first company to
directly identify and isolate
human neural stem cells from normal
brain tissue. Such statements reflect management's
current
views and are based on certain assumptions that may or may not
ultimately prove valid. Psycholinguistics
is a scientific discipline that deals with the actions and mental processes of people in their use language
.
perception cognition
Following completion of
these programs, Jacobs served as a resident neurosurgeon at the
University
of California, San Francisco Medical Center. is a development stage biotechnology company
focused
on the discovery, development and commercialization of stem
cell-based therapies to treat diseases
of the nervous system, liver
and pancreas.D. PLoS
publishes open-access journals of original peer
-reviewed research,
including PLoS Biology and PLoS Medicine, which are available at no
cost to
anyone in the world with a connection to the Internet.plos.psycholinguistic contribute
Business Editors/Health Editors
PALO ALTO, Calif.
"I am excited to put my experience in neurological research to
work for StemCells
, Inc.linguistics insights
StemCells Inc. Names Alan Jacobs Chief Medical Officer and Vice President of Clinical Research
Neural Program
psychopathology linguistics
StemCells does not undertake to update any of these
forward-looking statements
to reflect events or circumstances that
occur after the date hereof.
The Public Library of
Science (PLoS) is a non-profit organization
of scientists and physicians committed to making the
world's
scientific and medical research a public resource, founded by Dr.comprehension phenomena
D from the University of
Pennsylvania, David
Mahoney Institute of Neuroscience, and an M.
While NIH's Public Access Policy
could, and PLoS believes should,
have been stronger in several respects, it sets an important precedent
for all sponsors of scientific research. PLoS urges all scientists to
seize this opportunity to
ensure that their works are made freely
available to their colleagues and the public.contribute theoretical
Jacobs previously
served as medical director of
Layton Biosciences, where he was responsible for clinical and
regulatory
development of a neural cell line for the indications of
stroke and Parkinson's disease."
contribute neuropsychology
"I am committed to collaborating with the
full scientific team to reach StemCells' ultimate objective
--bringing
neural stem cell therapies to the clinic and providing treatments for
patients who currently
have few viable medical options.anthropological conveying
Working overtime to stay the Web's best reference!
-> Show SiteSeek's List of Web Sites For This Topic (Not Yet Peer Reviewed)
Loading...
(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)